2m 2m 2m 2m 2m 2m 2m
Cerus (CERS)
NASDAQ
$2.70-$0.005 (-0.19%)
Price as of Jun 03, 2026 7:11 PM EDT- $609.1MMarket Cap
- 87.50%1-Year Change
- Medical DevicesIndustry
Cerus (CERS)
$2.70-$0.005 (-0.19%)
CERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.70 | ||
Change | -$0.14 (-4.93%) | ||
Open | $2.81 | ||
High | $2.83 | ||
Low | $2.62 | ||
Previous Close | $2.84 | ||
Volume | 2,435,219 | ||
30-Day Average Volume | 2,593,443 | ||
1-Week Change | -1.10% | ||
1-Month Change | -0.74% | ||
1-Year Change | 87.50% | ||
3-Year Change | 19.47% | ||
5-Year Change | -51.96% | ||
Fundamentals | |||
Shares Outstanding | 200.4M | ||
Total Assets | $222.9M | ||
Market Cap | $609.1M | ||
Enterprise Value | $666.1M | ||
Period: QTR TTM FY | |||
Revenue | $53.7M | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$3.3M | ||
EBIT | -$1.5M | ||
EBITDA | -$1.1M | ||
Net Working Capital | $68.0M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -604 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 9 | ||
P/E | -304 | ||
PEG | -25 | ||
Price/Free Cash Flow | -186 | ||
Price/Operating Cash Flow | -200 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue